======= BLM ======= == Gene Information == * **Official Symbol**: BLM * **Official Name**: BLM RecQ like helicase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=641|641]] * **UniProt**: [[https://www.uniprot.org/uniprot/P54132|P54132]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BLM&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BLM|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604610|Open OMIM]] == Function Summary == * **Entrez Summary**: The Bloom syndrome gene product is related to the RecQ subset of DExH box-containing DNA helicases and has both DNA-stimulated ATPase and ATP-dependent DNA helicase activities. Mutations causing Bloom syndrome delete or alter helicase motifs and may disable the 3'-5' helicase activity. The normal protein may act to suppress inappropriate recombination. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: ATP-dependent DNA helicase that unwinds single- and double-stranded DNA in a 3'-5' direction (PubMed:9388193, PubMed:24816114, PubMed:25901030). Participates in DNA replication and repair (PubMed:12019152, PubMed:21325134, PubMed:23509288). Involved in 5'-end resection of DNA during double-strand break (DSB) repair: unwinds DNA and recruits DNA2 which mediates the cleavage of 5'-ssDNA (PubMed:21325134). Negatively regulates sister chromatid exchange (SCE) (PubMed:25901030). Stimulates DNA 4-way junction branch migration and DNA Holliday junction dissolution (PubMed:25901030). Binds single-stranded DNA (ssDNA), forked duplex DNA and DNA Holliday junction (PubMed:20639533, PubMed:24257077, PubMed:25901030). {ECO:0000269|PubMed:12019152, ECO:0000269|PubMed:20639533, ECO:0000269|PubMed:21325134, ECO:0000269|PubMed:23509288, ECO:0000269|PubMed:24257077, ECO:0000269|PubMed:24816114, ECO:0000269|PubMed:25901030, ECO:0000269|PubMed:9388193}. |DEAD| |BDHCT| |RQC| |Helicase C| |HRDC| |forked DNA-dependent helicase activity| |telomeric G-quadruplex DNA binding| |8-hydroxy-2-deoxyguanosine DNA binding| |cellular response to camptothecin| |telomeric D-loop binding| |Y-form DNA binding| |response to camptothecin| |four-way junction helicase activity| |annealing helicase activity| |G-quadruplex DNA unwinding| |DNA strand renaturation| |telomeric D-loop disassembly| |bubble DNA binding| |G-quadruplex DNA binding| |replication fork protection| |telomere maintenance via telomere trimming| |t-circle formation| |formation of extrachromosomal circular DNA| |cellular response to hydroxyurea| |response to hydroxyurea| |telomeric loop disassembly| |lateral element| |DNA unwinding involved in DNA replication| |four-way junction DNA binding| |response to antimetabolite| |negative regulation of cell division| |3-5 DNA helicase activity| |mitotic G2 DNA damage checkpoint| |DNA double-strand break processing| |negative regulation of DNA-dependent DNA replication| |replication fork| |nuclear chromosome| |mitotic G2/M transition checkpoint| |G2 DNA damage checkpoint| |response to X-ray| |replication fork processing| |helicase activity| |cellular response to alkaloid| |DNA-dependent DNA replication maintenance of fidelity| |negative regulation of DNA replication| |DNA-dependent ATPase activity| |negative regulation of DNA recombination| |chromosome, telomeric region| |regulation of DNA-dependent DNA replication| |DNA helicase activity| |p53 binding| |cellular response to ionizing radiation| |cellular response to alcohol| |negative regulation of G2/M transition of mitotic cell cycle| |response to antineoplastic agent| |mitotic DNA damage checkpoint| |double-strand break repair via homologous recombination| |regulation of cyclin-dependent protein serine/threonine kinase activity| |recombinational repair| |telomere maintenance| |PML body| |negative regulation of cell cycle G2/M phase transition| |telomere organization| |regulation of cyclin-dependent protein kinase activity| |regulation of DNA recombination| |mitotic DNA integrity checkpoint| |single-stranded DNA binding| |regulation of DNA replication| |nuclear matrix| |DNA duplex unwinding| |response to alkaloid| |DNA geometric change| |DNA-dependent DNA replication| |negative regulation of DNA metabolic process| |chromosome| |DNA damage checkpoint| |DNA integrity checkpoint| |response to ionizing radiation| |mitotic cell cycle checkpoint| |regulation of cell division| |cellular response to radiation| |regulation of signal transduction by p53 class mediator| |double-strand break repair| |cell cycle checkpoint| |regulation of G2/M transition of mitotic cell cycle| |regulation of cell cycle G2/M phase transition| |negative regulation of mitotic cell cycle phase transition| |DNA replication| |cellular response to inorganic substance| |DNA recombination| |negative regulation of cell cycle phase transition| |response to alcohol| |ATPase activity| |DNA conformation change| |negative regulation of mitotic cell cycle| |cellular response to abiotic stimulus| |cellular response to environmental stimulus| |negative regulation of cell cycle process| |protein homooligomerization| |anatomical structure homeostasis| |regulation of DNA metabolic process| |cellular response to drug| |regulation of mitotic cell cycle phase transition| |response to radiation| |regulation of cell cycle phase transition| |DNA repair| |regulation of protein serine/threonine kinase activity| |protein complex oligomerization| |response to inorganic substance| |cellular response to organic cyclic compound| |negative regulation of cell cycle| |mitotic cell cycle process| |cellular response to organonitrogen compound| |regulation of mitotic cell cycle| |cellular response to nitrogen compound| |mitotic cell cycle| |DNA metabolic process| |regulation of cell cycle process| |cellular response to DNA damage stimulus| |regulation of protein kinase activity| |zinc ion binding| |nucleolus| |regulation of kinase activity| |protein homodimerization activity| |response to organic cyclic compound| |regulation of transferase activity| |cell cycle process| |response to organonitrogen compound| |response to drug| |cellular response to oxygen-containing compound| |chromosome organization| |response to nitrogen compound| |response to abiotic stimulus| |regulation of cell cycle| |cellular response to endogenous stimulus| |cell cycle| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |regulation of protein phosphorylation| |DNA binding| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |ATP binding| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |protein-containing complex assembly| |regulation of phosphorylation| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |homeostatic process| |cellular response to stress| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of intracellular signal transduction| |regulation of protein modification process| |protein-containing complex subunit organization| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp518|RK-33 8μM R08 exp518]]|1.7| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|1.78| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|2.04| |[[:results:exp300|VE-822 0.04μM R06 exp300]]|2.39| |[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|2.72| |[[:results:exp512|Olaparib 4μM R08 exp512]]|2.83| |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|6.22| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|7| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|7.65| ^Gene^Correlation^ |[[:human genes:r:rmi1|RMI1]]|0.775| |[[:human genes:r:rmi2|RMI2]]|0.727| |[[:human genes:p:pml|PML]]|0.617| |[[:human genes:t:top3a|TOP3A]]|0.547| |[[:human genes:r:rrm1|RRM1]]|0.486| |[[:human genes:s:slfn11|SLFN11]]|0.417| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2477 * **Expression level (log2 read counts)**: 6.89 {{:chemogenomics:nalm6 dist.png?nolink |}}